There are some in vitro studies supporting, in some extent, our results, since a co‐culture of peripheral blood mononuclear cells from patients with spondyloarthritis treated with UC‐MSC inhibits the production of IL‐17.34 This evidence concerns the gene IL17A and spondyloarthropathy.